Shearman Logo

balance scale

Aug 13, 2013

Stock Options and Beyond

Subscribe

Jump to...

 

Nature Biotechnology published an article titled "Stock Options and Beyond" by Shearman & Sterling partner John J. Cannon III (New York-Compensation, Governance & ERISA) and of counsel Mark Kessel (New York-Capital Markets) on August 8, 2013.

In their article, Cannon and Kessel examine the advantages and disadvantages of stock options and the accounting, tax and other regulatory constraints associated with stock option programs and other equity-based remuneration.

View article, Stock Options and Beyond

Authors and Contributors

John J. Cannon III

Partner

Compensation, Governance & ERISA

+1 212 848 8159

+1 212 848 8159

New York

Mark Kessel

Of Counsel

Capital Markets

+1 212 848 4416

+1 212 848 4416

New York